Bewersdorf JP, Shallis RM, Derkach A, Goldberg AD, et al. Venetoclax-based salvage therapy in patients with relapsed/refractory acute myeloid leukemia previously treated with FLT3 or IDH1/2 inhibitors. Leuk Lymphoma 2022 Oct 26:1-9. doi: 10.1080/10428194.2022.2136952.
PMID: 36287540